Your browser doesn't support javascript.
loading
Prospective multicentre study in intensive care units in five cities from the Kingdom of Saudi Arabia: Impact of the International Nosocomial Infection Control Consortium (INICC) multidimensional approach on rates of central line-associated bloodstream infection.
Al-Abdely, Hail M; Alshehri, Areej Dhafer; Rosenthal, Victor Daniel; Mohammed, Yassir Khidir; Banjar, Weam; Orellano, Pablo Wenceslao; Assiri, Abdullah Mufareh; Kader, Nahla Moustafa Abedel; Enizy, Hessa Abdullah Al; Mohammed, Diaa Abdullah; Al-Awadi, Duaa Khalil; Cabato, Analen Fabros; Wasbourne, Maria; Saliya, Randa; Aromin, Rosita Gasmin; Ubalde, Evangelina Balon; Diab, Hanan Hanafy; Alkamaly, Modhi Abdullah; Alanazi, Nawal Mohammed; Hassan Assiry, Ibtesam Yahia; Molano, Apsia Musa; Flores Baldonado, Celia; Al-Azhary, Mohamed; Al Atawi, Sharifa; Molano, Apsia Musa; Al Adwani, Fatima Mohammad; Casuyon Pahilanga, Arlu Marie; Nakhla, Raslan; Al Adwani, Fatma Mohammad; Nair, Deepa Sasithran; Sindayen, Grace; Malificio, Annalyn Amor; Helali, Najla Jameel; Al Dossari, Haya Barjas; Kelany, Ashraf; Algethami, Abdulmajid Ghowaizi; Yanne, Leigh; Tan, Avigail; Babu, Sheema; Abduljabbar, Shatha Mohammad; Bukhari, Syed Zahid; Basri, Roaa Hasan; Mushtaq, Jeyashri Jaji; Rushdi, Hala; Turkistani, Abdullah Abdulaziz; Gonzales Celiz, Jerlie Mae; Al Raey, Mohammed Abdullah; Al-Zaydani Asiri, Ibrahim Am; Aldarani, Saeed Ali; Laungayan Cortez, Elizabeth.
Afiliação
  • Al-Abdely HM; General Directorate of Prevention and Infection Control, Ministry of Health, Riyadh, Saudi Arabia.
  • Alshehri AD; Assir Central Hospital, Assir, Saudi Arabia.
  • Rosenthal VD; General Directorate of Prevention and Infection Control, Ministry of Health, Riyadh, Saudi Arabia.
  • Mohammed YK; International Nosocomial Infection Control Consortium (INICC), Buenos Aires, Argentina.
  • Banjar W; General Directorate of Prevention and Infection Control, Ministry of Health, Riyadh, Saudi Arabia.
  • Orellano PW; Assir Central Hospital, Assir, Saudi Arabia.
  • Assiri AM; General Directorate of Prevention and Infection Control, Ministry of Health, Riyadh, Saudi Arabia.
  • Kader NMA; International Nosocomial Infection Control Consortium (INICC), Buenos Aires, Argentina.
  • Enizy HAA; Universidad Tecnológica Nacional, Facultad Regional San Nicolás and Consejo Nacional de Investigaciones Científicas y Técnicas, San Nicolás, Argentina.
  • Mohammed DA; General Directorate of Prevention and Infection Control, Ministry of Health, Riyadh, Saudi Arabia.
  • Al-Awadi DK; King Khalid Hospital, Najran, Saudi Arabia.
  • Cabato AF; King Khalid Hospital, Tabuk, Saudi Arabia.
  • Wasbourne M; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia.
  • Saliya R; Hera General Hospital, Makkah, Saudi Arabia.
  • Aromin RG; Assir Central Hospital, Assir, Saudi Arabia.
  • Ubalde EB; General Directorate of Prevention and Infection Control, Ministry of Health, Riyadh, Saudi Arabia.
  • Diab HH; General Directorate of Prevention and Infection Control, Ministry of Health, Riyadh, Saudi Arabia.
  • Alkamaly MA; King Khalid Hospital, Najran, Saudi Arabia.
  • Alanazi NM; King Khalid Hospital, Najran, Saudi Arabia.
  • Hassan Assiry IY; King Khalid Hospital, Najran, Saudi Arabia.
  • Molano AM; King Khalid Hospital, Najran, Saudi Arabia.
  • Flores Baldonado C; King Khalid Hospital, Najran, Saudi Arabia.
  • Al-Azhary M; King Khalid Hospital, Najran, Saudi Arabia.
  • Al Atawi S; King Khalid Hospital, Najran, Saudi Arabia.
  • Molano AM; King Khalid Hospital, Najran, Saudi Arabia.
  • Al Adwani FM; King Khalid Hospital, Najran, Saudi Arabia.
  • Casuyon Pahilanga AM; Assir Central Hospital, Assir, Saudi Arabia.
  • Nakhla R; King Khalid Hospital, Tabuk, Saudi Arabia.
  • Al Adwani FM; King Khalid Hospital, Tabuk, Saudi Arabia.
  • Nair DS; King Khalid Hospital, Tabuk, Saudi Arabia.
  • Sindayen G; King Khalid Hospital, Tabuk, Saudi Arabia.
  • Malificio AA; King Khalid Hospital, Tabuk, Saudi Arabia.
  • Helali NJ; King Khalid Hospital, Tabuk, Saudi Arabia.
  • Al Dossari HB; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia.
  • Kelany A; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia.
  • Algethami AG; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia.
  • Yanne L; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia.
  • Tan A; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia.
  • Babu S; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia.
  • Abduljabbar SM; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia.
  • Bukhari SZ; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia.
  • Basri RH; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia.
  • Mushtaq JJ; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia.
  • Rushdi H; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia.
  • Turkistani AA; Hera General Hospital, Makkah, Saudi Arabia.
  • Gonzales Celiz JM; Hera General Hospital, Makkah, Saudi Arabia.
  • Al Raey MA; Hera General Hospital, Makkah, Saudi Arabia.
  • Al-Zaydani Asiri IA; Hera General Hospital, Makkah, Saudi Arabia.
  • Aldarani SA; Hera General Hospital, Makkah, Saudi Arabia.
  • Laungayan Cortez E; Assir Central Hospital, Assir, Saudi Arabia.
J Infect Prev ; 18(1): 25-34, 2017 Jan.
Article em En | MEDLINE | ID: mdl-28989500
ABSTRACT

OBJECTIVE:

To analyse the impact of the International Nosocomial Infection Control Consortium (INICC) Multidimensional Approach (IMA) and INICC Surveillance Online System (ISOS) on central line-associated bloodstream infection (CLABSI) rates in five intensive care units (ICUs) from October 2013 to September 2015.

DESIGN:

Prospective, before-after surveillance study of 3769 patients hospitalised in four adult ICUs and one paediatric ICU in five hospitals in five cities. During baseline, we performed outcome and process surveillance of CLABSI applying CDC/NHSN definitions. During intervention, we implemented IMA and ISOS, which included (1) a bundle of infection prevention practice interventions; (2) education; (3) outcome surveillance; (4) process surveillance; (5) feedback on CLABSI rates and consequences; and (6) performance feedback of process surveillance. Bivariate and multivariate regression analyses were performed.

RESULTS:

During baseline, 4468 central line (CL) days and 31 CLABSIs were recorded, accounting for 6.9 CLABSIs per 1000 CL-days. During intervention, 12,027 CL-days and 37 CLABSIs were recorded, accounting for 3.1 CLABSIs per 1000 CL-days. The CLABSI rate was reduced by 56% (incidence-density rate, 0.44; 95% confidence interval, 0.28-0.72; P = 0.001).

CONCLUSIONS:

Implementing IMA through ISOS was associated with a significant reduction in the CLABSI rate in the ICUs of Saudi Arabia.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: J Infect Prev Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Arábia Saudita

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: J Infect Prev Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Arábia Saudita